Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ·Healthcare·Biotechnology
$12.73
-0.90%
Mkt Cap $178.27M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $2.97M | $5.39M | +81.69% | -$3.16 | -$3.98 | -25.95% | — | — |
| Q4 2025 Nov 10, 2025 | $2.97M | $3.29M | +10.90% | -$3.59 | -$3.59 | +0.00% | — | — |
| Q3 2025 Aug 11, 2025 | $2.43M | $2.00M | -17.89% | -$3.10 | -$3.86 | -24.52% | — | — |
| Q2 2025 May 12, 2025 | $2.65M | $2.43M | -8.34% | -$3.23 | -$2.84 | +12.07% | — | — |
| Q1 2025 Mar 18, 2025 | $3.20M | $2.58M | -19.31% | -$6.23 | -$9.77 | -56.82% | — | — |
| Q4 2024 Nov 12, 2024 | $3.40M | $2.82M | -17.00% | -$203.00 | -$23.00 | +88.67% | — | — |
| Q3 2024 Aug 16, 2024 | $3.58M | $2.21M | -38.32% | -$991.00 | -$1928.00 | -94.55% | — | — |
| Q2 2024 Apr 1, 2024 | $3.80M | $2.48M | -34.68% | -$4984.03 | -$2747.60 | +44.87% | — | — |
| Q1 2024 Mar 25, 2024 | $3.83M | $3.78M | -1.33% | -$1.64 | -$0.86 | +47.56% | — | — |
| Q4 2023 Nov 9, 2023 | $5.13M | $3.99M | -22.24% | -$4760.38 | -$5846.65 | -22.82% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$8881.79 | -$8562.30 | +3.60% | — | — |
| Q2 2023 May 8, 2023 | — | $33.90M | — | -$7987.22 | -$10383.40 | -30.00% | — | — |
| Q1 2023 Mar 13, 2023 | — | — | — | -$12579.90 | -$11182.10 | +11.11% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$14377.00 | -$13778.00 | +4.17% | — | — |
| Q3 2022 Aug 8, 2022 | — | $9.03M | — | -$29153.40 | -$24361.00 | +16.44% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$31897.80 | -$31897.80 | +0.00% | — | — |
| Q1 2022 Mar 14, 2022 | — | — | — | -$44657.00 | -$44657.00 | +0.00% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$44657.00 | -$31897.80 | +28.57% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$44657.00 | -$44657.00 | +0.00% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$38277.40 | -$44657.00 | -16.67% | — | — |